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Summary
Cell surface lipoproteins are important for the full
virulence of several bacterial pathogens, including
Streptococcus pneumoniae. Processing of prolipo-
proteins seems to be conserved among different bac-
terial species, and requires type II signal peptidase
(Lsp) mediated cleavage of the N-terminal signal
peptide to form the mature lipoprotein. Lsp has been
suggested as a target for new antibiotic therapies, but
at present there are only limited data on the function
of Lsp for Gram-positive bacterial pathogens. We
have investigated the function and role during
disease pathogenesis of the S. pneumoniae Lsp,
which, BLAST searches suggest, is encoded by the
gene Sp0928. Expression of Sp0928 protected
Escherichia coli against the Lsp antagonist globomy-
cin, and proteomics and immunoblot analysis
demonstrated that deletion of Sp0928 prevented pro-
cessing of S. pneumoniae prolipoproteins to mature
lipoproteins. These data strongly suggest that
Sp0928 encodes the S. pneumoniae Lsp. However,
immunoblots of membrane-associated proteins,
immunoelectron microscopy and ﬂow cytometry
assays all conﬁrmed that in the absence of Lsp,
immature lipoproteins were still attached to the cell
surface. Despite preservation of lipoprotein attach-
ment to the cell membrane, loss of S. pneumoniae
Lsp resulted in several phenotypes associated with
impaired lipoprotein function and reduced S. pneu-
moniae replication in animal models of infection.
Introduction
Bacterial surface proteins are important for the interaction
of bacterial pathogens with their environment during infec-
tion and, as a consequence, are frequently involved in
disease pathogenesis. One large category of bacterial
surface proteins is the lipoproteins. Lipoproteins are
important components of ABC transporters, transmem-
brane structures involved in the import or export of a wide
range of substrates, including sugars, amino acids, oli-
gopeptides, polyamines, various metal ions and minerals
(Garmory and Titball, 2004). ABC transporters contribute
to many bacterial processes, such as acquisition of vital
nutrients, stress responses and intercellular signalling,
many of which could be vital for bacterial growth and
survival within the host. Signature-tagged mutagenesis
(STM) screens for virulence genes and detailed investi-
gations of individual ABC transporters have conﬁrmed
that ABC transporters do indeed have signiﬁcant roles
during disease pathogenesis for a range of bacteria,
including the important Gram-positive respiratory and sys-
temic pathogen Streptococcus pneumoniae (Mei et al.,
1997; Chiang and Mekalanos, 1998; Polissi et al., 1998;
Lau et al., 2001; Hava and Camilli, 2002). S. pneumoniae
ABC transporters that affect interactions with the host
include the pneumococcal surface adhesin A (PsaA), a
manganese uptake transporter required for resistance to
oxidative stress and adherence to host cells (Dintilhac
et al., 1997; Marra et al., 2002), the Piu, Pit and Pia iron
uptake transporters (Brown et al., 2001a; 2002), the Ami–
AliA/B oliogpeptide transporters (Kerr et al., 2004) and
several uncharacterized ABC transporters identiﬁed by
STM screens (Polissi et al., 1998; Lau et al., 2001; Hava
and Camilli, 2002).As well as lipoproteins associated with
ABC transporter function, the S. pneumoniae genome
also encodes at least 15 other lipoproteins (Tettelin et al.,
2001). The functions of many of these non-ABC trans-
porter lipoproteins are unknown, but two, PpmA (putative
proteinase maturation protein A) and SlrA (streptococcal
Accepted 17 November, 2007. *For correspondence. E-mail jeremy.
brown@ucl.ac.uk; Tel. (+44) 20 7679 6008; Fax (+44) 20 7679 6973.
Re-use of this article is permitted in accordance with the Creative
Commons Deed, Attribution 2.5, which does not permit commercial
exploitation.
 OnlineOpen: This article is available free online at www.blackwell-synergy.com
Molecular Microbiology (2008) 67(3), 541–557  doi:10.1111/j.1365-2958.2007.06065.x
First published online 16 December 2007
© 2007 The Authors
Journal compilation © 2007 Blackwell Publishing Ltdlipoprotein rotamase A), belong to the chaperone family
of peptidyl-prolyl isomerases and contribute to
S. pneumoniae colonization, avoidance of phagocytosis
and pulmonary infection (Overweg et al., 2000; Hermans
et al., 2006).
Lipoproteins are covalently attached to the extracellular
surface of the cell membrane by a mechanism that seems
to be largely conserved among eubacteria (Sutcliffe and
Harrington,2002).Initially,prolipoproteinsaresecretedout
of the cell by the general secretory pathway, and this is
directed by an N-terminal signal peptide sequence. After
secretion, lipoproteins are covalently linked to the cell
membrane by the enzyme diacylglyceryl transferase (Lgt),
which catalyses the attachment of the thiol of a universally
conserved cysteine residue within the ‘lipobox’ domain of
the lipoprotein signal peptide to membrane phospholipid
diacylglycerol (Tokunaga et al., 1982; Inouye et al., 1983;
Sutcliffe and Harrington, 2002). A type II lipoprotein signal
peptidase (Lsp) then cleaves the N-terminal signal peptide
adjacent to the ‘lipobox’ cysteine residue to form the
mature lipoprotein. In Gram-negative bacteria, the mature
lipoprotein undergoes additional modiﬁcation by attach-
ment of an amide-linked fatty acid to the N-terminal cys-
teine residue of the lipoprotein by an N-acyl transferase
(Lnt), but an equivalent enzyme is not found in Gram-
positivegenomes(SankaranandWu,1994;Tjalsmaet al.,
1999a; Sutcliffe and Harrington, 2002).
The importance of lipoproteins for disease pathogen-
esis suggests that inhibition of lipoprotein processing by
Lsp may strongly affect bacterial virulence. However,
despite the conservation of the pathway for processing
lipoproteins, the available data on the effects of inhibition
of Lsp function indicate that these are surprisingly variable
between bacterial species. For example, inhibition of Lsp
is toxic to Escherichia coli, yet only affects growth of
Bacillus subtilis under stress conditions (Inouye et al.,
1983; Tjalsma et al., 1999a). At present, there are no
published data on Lsp function in S. pneumoniae, and
only limited data for other Gram-positive pathogens, with
reports available on the effects of deletion or disruption of
lsp for Mycobacterium tuberculosis, Listeria monocytoge-
nes and Streptococcus suis (De Greef et al., 2003;
Reglier-Poupet et al., 2003; Sander et al., 2004). Disrup-
tion of lsp in M. tuberculosis had no detectable effect on
growth or cell morphology, but did result in the accumu-
lation of unprocessed forms of the two lipoproteins inves-
tigated (Sander et al., 2004). Similarly, disruption of lsp in
L. monocytogenes and S. suis resulted in the retention of
the N-terminal signal peptides for the limited number of
lipoproteins investigated (De Greef et al., 2003; Reglier-
Poupet et al., 2003). However, the effects of loss of Lsp
on virulence varied between species, with a strong effect
on M. tuberculosis, impaired intracellular growth and mod-
erately attenuated virulence for L. monocytogenes, but no
effect on the virulence of S. suis (De Greef et al., 2003;
Reglier-Poupet et al., 2003; Sander et al., 2004). STM
screens have also identiﬁed lsp as probably required for
Staphylococcus aureus virulence (Mei et al., 1997). In
addition, disruption of lgt in different bacterial species has
a variable effect on virulence, rendering S. pneumoniae
avirulent in a mouse model of pneumonia, only partially
attenuating the virulence of Streptococcus equi and actu-
ally increasing the virulence of S. aureus (Petit et al.,
2001; Hamilton et al., 2006; Wardenburg et al., 2006).
The S. pneumoniae genome contains a putative four-
gene operon (gene numbers Sp0927–0930 in the TIGR4
S. pneumoniae genome), one of which (Sp0928), BLAST
searches suggest, is likely to encode the S. pneumoniae
Lsp (Tettelin et al., 2001). Two S. pneumoniae STM
screensindependentlyidentiﬁedmutantscontaininginser-
tions in the ﬁrst gene of this putative operon, indicating that
this operon is likely to be important for disease pathogen-
esis (Lau et al., 2001; Hava and Camilli, 2002). However,
the Sp0927–0930 operon also contains genes encoding
CbpE (Sp0930), a choline-binding protein involved with
processing cell wall phosphorylcholine (Hermoso et al.,
2005), and a LysR regulator (Sp0927), loss of function of
which might also affect virulence, and why this putative
operon is required for disease pathogenesis needs further
evaluation. In this study, we have investigated the function
oftheproductofS.pneumoniaeSp0928,characterizingits
potential role as an Lsp and for lipoprotein function, and
assessing its importance during disease pathogenesis in
mouse models of S. pneumoniae infection.
Results
Genetic organization of the Sp0927–0930 operon and
creation of an Sp0928 deletion mutant
The Sp0927–0930 locus of the S. pneumoniae TIGR4
genome consists of four genes with overlapping open
reading frames (ORFs) that are transcribed in the same
direction (Fig. 1A). Reverse transcriptase polymerase
chain reaction (RT-PCR) analysis of this locus using
primers designed to span the junctions of each gene
conﬁrmed that all four genes are co-transcribed as a
single transcript that terminates after Sp0930 (data not
shown). BLAST searches show that the protein encoded by
the second gene in this operon, Sp0928, has a high
degree of identity and similarity to proven and putative
Lsp enzymes of other bacteria (Table 1), and Sp0928 has
been annotated as lsp in the TIGR4 genome sequence
(Tettelin et al., 2001). Analysis using hidden Markoff
Models and HMMTOP software (Tusnady and Simon,
1998) predicts that the sequence of the protein product
of Sp0928 has four transmembrane domains and two
extracellular loops as suggested for other Lsp proteins
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Fig. 1. A. Organization of the Sp0927–0930 loci, with assigned gene names above the arrows and the TIGR4 genome gene number below
the line. Arrows indicate transcriptional direction, and the putative lsp gene is shaded with diagonal lines.
B. Alignment of the derived protein sequence of Sp0928 (S. pneu) to the conserved domains of the B. subtilis (B. sub) Lsp (Tjalsma et al.,
1999). The six residues required for Lsp activity are marked in bold, and are 100% conserved between the B. subtilis Lsp and the protein
encoded by SP0928.
C. Structure of the Sp0927–930 locus in the D0928 mutant strain derived from the wild-type 0100993 strain, showing replacement of Sp0928
with an in-frame copy of ery
r.
D. Structure of the Sp0927–930 locus in the 0928C mutant strain derived from the D0928 mutant strain, showing replacement of the ery
r
cassette with an in-frame copy of Sp0928 (lsp) and cat.
E. Ethidium bromide stained agarose gels showing RT-PCR analysis of the Sp0927–0930 locus in the wild-type, D0928 and 0928C strains.
Primers were designed to amplify internal portions of each gene within the locus, using the following primer pairs: Sp0927F and Ery-Sp0927R
for Sp0927; Sp0928F and Sp0928R for Sp0928; Ery-Sp0929F and Sp0929R for Sp0929; and Sp0930F and Sp0930R for Sp0939. Reactions
not containing reverse transcriptase gave no products (not shown). The mean (SD in brackets) relative transcription of each gene in the
mutant strains compared with the wild-type strain (obtained using real-time RT-PCR) is stated below the corresponding band in the gel.
No product was obtained for Sp0928 in the D0928 mutant strain.
Table 1. Identity and similarity of the predicted amino acid sequence of Sp0928 to the predicted amino acid sequences of Lsp for other bacterial
species.
Organism Gene number % identity/similarity
Length of amino
acids compared
Streptococcus pyogenes Spy_0637 64/76 137
Streptococcus mutans SMU.853 62/79 138
S. suis SSU05_0785 55/73 138
Lactococcus lactis Llmg_1525 51/71 132
B. subtilus BSU15450 38/59 131
L. monocytogenes LMRG_00991 38/59 135
S. aureus SAB1060 38/63 136
M. tuberculosis TBFG_11572 34/53 133
E. coli ECP_0025 34/54 128
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Sp0928 product contains domains with a high degree of
identity to the B. subtilis Lsp conserved regions I to V,
including conservation of all of the six amino acids that
are important for Lsp activity (Fig. 1B; Tjalsma et al.,
1999b). The other proteins encoded by the genes within
this operon are a putative LysR regulator (Sp0927),
a pseudouridine synthase (Sp0929), and the choline-
binding protein termed CbpE that is involved in the pro-
cessing of cell wall phosphorylcholine and adhesion to
host cells (Sp0930; Hermoso et al., 2005). There are no
published data on the function of Sp0927, Sp0928 and
Sp0929, although STM screens have identiﬁed strains
with polar mutations in Sp0927 as attenuated in virul-
ence (Lau et al., 2001; Hava and Camilli, 2002). The
Sp0927–0930 locus is conserved among the sequenced
S. pneumoniae genomes, and as previously reported,
homologues of Sp0927, Sp0928 and Sp0929 are orga-
nized as probable operons in other streptococcal species
(De Greeff et al., 2003).
To study the role of Lsp in S. pneumoniae, an isogenic
non-polar deletion mutant (D0928) with the Sp0928 gene
replaced by an erythromycin resistance cassette (erm)
was constructed using overlap extension PCR (Fig. 1C).
An additional strain was constructed in which the D0928
strain was complemented by replacement of the erm cas-
sette with an in-frame copy of Sp0928 combined with the
chloramphenicol-resistant marker cat (termed 0928C;
Fig. 1D). RT-PCR analysis of the mutant strains demon-
strated that the Sp0928 product was absent in the D0928
strain but was present in the wild-type and 0928C strains,
and conﬁrmed that the mutations affecting Sp0928 were
non-polar and did not prevent transcription of Sp0929 and
Sp0930 (Fig. 1E). No products were obtained for RT-PCR
reactions that did not contain reverse transcriptase, dem-
onstrating that contaminating DNA was not responsible
for the results obtained. As non-quantitative RT-PCR sug-
gested there was some dysregulation of gene expression
in the 0928C strain (Fig. 1E), the relative levels of tran-
scripts for all three strains were compared using real-time
RT-PCR (Fig. 1E). The results show that in the D0928
strain, transcription of Sp0927, Sp0929 and Sp0930 was
not signiﬁcantly affected. However, transcription of all four
genes was signiﬁcantly disrupted in the complemented
strain, with increased expression of Sp0927 and Sp0928
and decreased expression of Sp0929 and Sp0930 com-
pared with the wild-type and D0928 strains.
Sp0928 antagonises globomycin toxicity in E. coli
The antibiotic globomycin speciﬁcally inhibits Lsp function
(Inukaiet al.,1978)andistoxictoE.coli,probablybecause
of the accumulation of pro-lipoproteins in the inner mem-
brane. Both Gram-negative and Gram-positive bacterial
lsp genes expressed in E. coli antagonize globomycin
toxicity, and therefore confer resistance to this
antibiotic, and this property has been used widely to dem-
onstrate Lsp activity for proteins encoded by putative lsp
genes (Pragai et al., 1997; De Greeff et al., 2003; Rahman
et al., 2007). Hence, in order to demonstrate that Sp0928
encodes an Lsp, the full-length Sp0928 gene was ligated
into the expression vector pQE30UAand transformed into
E. coli.As indicated by optical density (OD) measurements
(Fig. 2), E. coli expressing S. pneumoniae Sp0928 grew
well in the presence of increasing concentrations of globo-
mycin up to 320 mgm l -1. In contrast, growth of a negative
control E. coli strain expressing a S. pneumoniae lipopro-
tein (Sp0149, S. Basavanna and J. Brown, unpubl. data)
was inhibited at all the concentrations of globomycin used.
These results strongly suggest that Sp0928 does encode
an Lsp enzyme and can be termed lsp.
Loss of Sp0928 results in increased lipoprotein
size compatible with retention of the N-terminal
signal peptide
In order to assess the effect of deletion of lsp on the
processing of S. pneumoniae lipoproteins, Western blots
of whole-cell lysates of the wild-type and the D0928 and
0928C mutant strains were probed with polyclonal mouse
or rabbit antibodies to three lipoproteins (PiuA, PiaA and
PsaA) that are constituents of metal ion uptake ABC
transporters, and two lipoproteins that are not associated
with ABC transporters (SlrA and PpmA) (Dintilhac et al.,
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Fig. 2. Globomycin-resistance assay. Resistance of E. coli
expressing full-length Sp0928 (clear columns) or a lipoprotein
(Sp0149, black columns) to increasing concentrations of
globomycin, measured by OD600 after overnight culture in LB broth
at 37°C. For the comparison of the results between Sp0928 and
Sp0149, P < 0.001 at all concentrations of globomycin (Student’s
t-test).
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lipoprotein in the D0928 strain had a slightly higher
molecular weight compared with the wild-type strain
(Fig. 3), compatible with retention of the N-terminal signal
peptide sequence which ranges from 18 to 23 amino
acids in length for these lipoproteins. When used to probe
the D0928 strain, antibodies to SlrA and PpmA also seem
to result in an additional lower-intensity signal closer in
size to the processed lipoprotein, possibly suggesting that
for these lipoproteins loss of lsp may not completely
prevent N signal peptide processing. Immunoblots using
an antibody to pneumolysin, a non-lipoprotein S. pneumo-
niae protein, resulted in similar sized bands for the
wild-type and D0928 strains (Fig. 3), indicating that the
increase in protein size in the D0928 strain was speciﬁc
for lipoproteins. In the complemented strain 0928C,
immunoblots for lipoproteins identiﬁed either a single
band of similar size to the band in the wild-type strain or
two bands corresponding to the bands seen in both the
wild-type and D0928 strains, suggesting the 0928C strain
has incomplete complementation of Lsp function. Immu-
noblots using antibodies to PiuA and lysates of a 50/50
mixture of the wild-type and D0928 strains produced two
bands corresponding in size to those seen in the immu-
noblots of the separate wild-type and D0928 bacteria,
conﬁrming that the small differences in size in the proteins
were not due to differences in running speed between
lanes (data not shown).
Lipoproteins in the D0928 strain are localized
to the cell membrane
The localization of lipoproteins in the D0928 strain was
investigated using immunoblots of Triton X-114 extrac-
tions probed with antibodies to the S. pneumoniae
lipoproteins. Triton X-114 is a non-ionic detergent which
solubilizes and extracts integral membrane proteins into
the detergent phase, with hydrophilic proteins partitioning
into the aqueous phase (Bordier, 1981). For all three of
the wild-type, D0928 and 0928C strains, the immunoblots
demonstrated that all the lipoproteins investigated were in
the detergent phase with no detectable signal in the
aqueous phase, whereas for the negative control pneu-
molysin, there was no detectable protein in the detergent
phase (Fig. 3). These results indicate that in the D0928
mutant strain, despite loss of Lsp function, the lipoproteins
are still localized to the membrane. Surface accessibility
of lipoproteins in the D0928 strain was conﬁrmed using
ﬂow cytometry to assess the binding of antibodies to
PiuA, SlrA and PpmA to live S. pneumoniae cells, using
the piuB –, slrA – and ppmA – mutants (JSB3SlrA – and
JSB3ppmA –) strains as negative controls (Brown et al.,
2001a; Hermans et al., 2006) (Fig. 4). Only very low levels
of binding to each lipoprotein-deﬁcient mutant strain were
seen with the corresponding antibody, conﬁrming the
speciﬁcity of the assay. There was signiﬁcant binding of
antibodies to PiuA, SlrA and, at a lower level, PpmA in the
wild-type, D0928 and 0928C strains, indicating that in all
three strains, these lipoproteins are surface accessible.
The level of binding of anti-PiuA was higher to both the
D0928 and 0928C strains compared with the wild-type
strain, whereas the level of binding of anti-SlrA was lower
to both the D0928 and 0928C strains compared with the
wild-type strain. To further demonstrate surface expres-
sion of lipoproteins in the D0928 strain, immunoelectron
microscopy was performed using antibodies to the intra-
cellular protein pneumolysin (as a control), and to PpmA
and SlrA. Similar studies could not be done with anti-PiuA,
Fig. 3. Immunoblots using antibodies to S.
pneumoniae lipoproteins (PsaA, PiuA, PiaA,
SlrA and PpmA) and pneumolysin (Ply) to
probe whole-cell lysates and the lipid and
aqueous phases of Triton X-114 extracts of
wild-type, D0928 and 0928C bacteria. Sizes of
lipoproteins were approximately 1–2 kDa
larger in the D0928 strain, and in the wild-type
strain were similar to the puriﬁed recombinant
lipoprotein without the N-terminal signal
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immunoelectron microscopy. All three proteins were
detected, but there was a marked difference in the pat-
terns of distribution between pneumolysin and the lipopro-
teins (Fig. 5). Pneumolysin was mainly detected within the
cell, whereas SlrA and PpmA were detected almost
entirely on the surface of the bacteria with no discernible
differences in the distribution pattern identiﬁed between
the wild-type and D0928 strains. Overall, the data
obtained from the immunoblots of Triton X-114 extrac-
tions, ﬂow cytometry and immunoelectron microscopy
demonstrate that in the D0928 strain the unprocessed
lipoproteins are still surface-expressed and attached to
the cell membrane.
Global analysis of S. pneumoniae lipoproteins in the
D0928 strain
The band patterns of Coomassie stained gels of Triton
X-114 extracts from the wild-type and D0928 strains were
signiﬁcantly different (Fig. 6), suggesting that there were
major differences in lipoproteins between these strains. To
precisely identify the proteins within these bands, they
were excised, digested in gel using trypsin, and the
digests analysed by liquid chromatography/tandem mass
spectrometry. Proteins were identiﬁed by interrogation of
the translated genomic database of S. pneumoniae strain
TIGR4. Sixteen lipoproteins were identiﬁed in the Triton
X-114 extracts from the wild-type and D0928 (Table 2),
with a median of four (range 2–23) peptides sequenced
per protein, resulting in a median coverage of the proteins’
Fig. 4. Flow cytometry analysis of the
expression of the lipoproteins PiuA (A), SlrA
(B) and PpmA (C) on the surface of live
wild-type, D0928 and 0928C S. pneumoniae
strains. As a control for non-speciﬁc binding of
the antisera, strains deﬁcient in expression of
PiuA (piuB
–, Brown et al., 2001a), PpmA or
SlrA (ppmA
– and slrA
–, Hermans et al., 2006)
are included. Binding of anti-PiuA, anti-SlrA
and anti-PpmA was signiﬁcantly greater for
the wild-type, D0928 and 0928C strains




mutant strains respectively (P < 0.05 for all
strains, Student’s t-test). Expression of PiuA
was greater on the D0928 and 0928C strains
compared with the wild-type (P < 0.01), and
the expression of SlrA was less on the D0928
and 0928C strains compared with the wild
type (P < 0.01).
D. Example of ﬂow cytometry histograms for
the wild-type (black line), D0928 (dashed line)
and piuB
































































































Fig. 5. Immunoelectron microscopy of thin sections of the
wild-type and D0928 S. pneumoniae strains using antibodies to the
PpmA and SlrA lipoproteins. Controls with bacteria stained with the
secondary antibody alone demonstrated only one or two gold
particles per cell (not shown), and controls probed with anti-Ply are
included to demonstrate the pattern of protein expression for an
intracellular protein. The scale bar in the top right panel is 0.2 mm
long.
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and a median probability of correct identiﬁcation of the
protein of 3.9 ¥ 10-7 (range from 1.3 ¥ 10-3 to 6.6 ¥ 10-13).
The estimated sizes of nearly all the identiﬁed lipoproteins
were slightly larger than the sizes predicted from the
derived amino acid sequence for the corresponding gene,
probably reﬂecting the presence of lipid attached to the
proteins in the Triton X-114 extracts (Table 2). There were
clear differences between the wild-type and the D0928
strain in the estimated size of the majority of the lipopro-
teins (Fig. 6). In all cases except band 3 (Sp0092), these
differences were an increase in the mass of the lipopro-
tein in the D0928 strain similar to the predicted increase in
lipoprotein size if the N-terminal signal peptide was
retained (Table 2). Complementation of strain D0928
restored the mass of each lipoprotein to that observed in
the wild-type strain (Fig. 6). These data demonstrate that
deletion of Sp0928 has global effects on lipoproteins com-
patible with loss of Lsp function.
Analysis of phenotypes associated with ABC transporter
functions in the D0928 strain
As lipoproteins form integral constituents of ABC trans-
porters, we hypothesized that unprocessed lipoproteins in
D0928 could lead to impaired ABC transporter function.
We therefore analysed whether the D0928 strain had phe-
notypes similar to those previously associated with loss of
function of some of the described S. pneumoniae ABC
transporters.
The S. pneumoniae manganese uptake ABC trans-
porter PsaA is required for resistance to oxidative
stress (Tseng et al., 2002; Chattopadhyay et al., 2003),
and impaired S. pneumoniae ABC transporter function
should lead to increased sensitivity to oxidative stress.
































Fig. 6. Coomassie stained SDS-PAGE of Triton X-114 extracts
from wild-type, 0928C and D0928 S. pneumoniae strains.
Numbered lines correspond to the band numbers shown in Table 2,
and the gels are aligned so that the migration positions of
molecular mass markers (marked for the D0928 strain gel) are
identical between the three gels.
Table 2. Identity according to LC-MS/MS data and estimated size of proteins present in the corresponding band number for the Triton X-114


















1 Sp1527 AliB 70.1 2.5 > 66 > 66
1 Sp 1891 AmiA 70.3 2.2 > 66 > 66
2 Sp2169 AdcA 54.3 1.9 59.2 61.8
3 Sp0092 Unknown function ABC transporter lipoprotein 52.1 2.4 54.4 53.2
4 Sp2108 MalX 42.9 2.4 47.8 50.0
5 Sp1683 Putative sugar ABC transporter lipoprotein 46.2 2.1 45.8 47.8
6 Sp1032 PiaA 35.3 2.2 43.0 45.8
7 Sp0845 Unknown function ABC transporter lipoprotein 34.6 2.1 39.5 41.2
7 Sp0981 PpmA 32.4 2.0 39.5 41.2
8 Sp1650 PsaA 32.6 2.0 37.8 38.6
9 Sp0149 Unknown function ABC transporter lipoprotein 29.0 2.2 34.0 36.2
9 Sp0771 SlrA 27.4 1.7 34.0 36.2
10 Sp1400 PstS 28.7 2.5 31.9 34.0
10 Sp0148 Unknown function ABC transporter lipoprotein 28.3 2.3 31.9 34.0
11 Sp1500 Putative amino acid-binding lipoprotein AatB 28.8 2.2 29.9 31.9
11 Sp0629 Conserved hypothetical protein 24.4 2.0 29.9 31.9
a. Some bands contained more than one lipoprotein.
b. Annotation for the corresponding gene within the TIGR4 genome (Tettelin et al., 2001).
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redox compounds paraquat and hydrogen peroxide,
using the psaA – (JSB3psaA –) strain as a positive control
(Hassett et al., 1987; Tseng et al., 2002). After exposure
to 60 mM paraquat for 60 min, all the D0928 strain and
96% of the psaA – strain had been killed, whereas the
colony-forming units (cfu) of the wild-type and 0928C
strains were 20% and 12%, respectively, of the inoculum
(Fig. 7A). Similar results were obtained when the strains
were exposed to 2 mM H2O2 (data not shown). These
data show that the D0928 strain is more susceptible to
oxidative stress.
Mutations affecting the phosphate uptake ABC trans-
porter lipoprotein PstS result in increased sensitivity to
penicillin (Soualhine et al., 2005). To test whether the
D0928 strain was more sensitive to penicillin, the wild-
type, D0928, 0928C and a pstS – (JSB3PstS –, as a posi-
tive control) strains were cultured in Todd Hewitt Yeast
(THY) broth in the presence of low concentrations of
penicillin, and the extent of growth assessed by measur-
ing the OD580 after 10 h of incubation. At a penicillin con-
centration of 7.5 ng ml-1, the OD580 for the D0928 and
pstS – strains were markedly lower compared with the
wild-type and 0928C strains (Fig. 7B), demonstrating
that the D0928 strain has increased sensitivity to
penicillin.
Streptonigrin is an antibiotic which requires the pres-
ence of intracellular iron for its bactericidal action
(Yeowell and White, 1982), and increased resistance to
streptonigrin has been associated with mutations affect-
ing the iron uptake ABC transporters Piu, Pia and Pit
(Brown et al., 2001a; 2002). The effect of streptonigrin
on the survival of the wild-type, D0928, 0928C and
double-mutant piuB –/piaA – (as a positive control) strains
was studied by incubating the strains with 2 mgm l -1
streptonigrin and by determining the proportion of bac-
teria surviving by plating serial dilutions. After 30 min
incubation, 55% of the D0928 strain survived, a similar
proportion to the iron uptake ABC transporter double-
mutant piuB –/piaA – strain, but signiﬁcantly greater than
the proportion of the wild-type or 0928C strains surviving
(less than 44%; Fig. 7C). These results suggest that the
intracellular iron concentration was lower in the D0928
strain, and therefore that iron transport into the cell,
which is mainly reliant on ABC transporters, may be par-
tially impaired.
Zinc and manganese ions are a speciﬁc requirement for
competence stimulating peptide (CSP)-induced S. pneu-
moniae transformation, and mutants affecting the zinc
and manganese ABC transporters Adc and Psa respec-
tively have reduced transformation efficiency (Dintilhac
et al., 1997). To investigate whether the D0928 strain had
a similar phenotype, a transformation efficacy assay was
performed using genomic DNA from an S. pneumoniae
strain carrying a kanamycin-resistant marker as donor
DNA and the wild-type, D0928 and 0928C strains as
parent strains. The D0928 strain was resistant to transfor-
mation, with very few transformants obtained, whereas
transformation of both the wild-type and 0928C strains
resulted in large numbers of transformants (Fig. 7D).
Fig. 7. ABC transporter phenotype assays
for the wild-type (clear columns), D0928
(black columns) and 0928C (grey columns)
strains.
A. Proportion of bacteria surviving incubation
with 60 mM paraquat for 60 min, using the
oxidative stress-sensitive psaA
– strain
(diagonal shading) as a positive control.
P < 0.01 (ANOVA) for the D0928 and psaA
–
strains versus the wild-type or 0928C strains.
B. OD580 after incubation in THY broth
containing 7.5 ng ml
-1 penicillin for 10 h, using
the penicillin-sensitive pstS
– strain (diagonal
shading) as a positive control. P < 0.05
(ANOVA) for the D0928 and pstS
– strains
versus the wild-type or 0928C strains.
C. Proportion of bacteria surviving incubation
with 2 mgm l
-1 streptonigrin for 30 min, using
the partially streptonigrin-resistant piuB
–/piaA
–
strain (diagonal shading) as a positive control.
P < 0.001 (ANOVA) for the D0928 and
piuB
–/piaA
– strains versus the wild-type or
0928C strains.
D. Number of kanamycin-resistant
transformants obtained when transforming
wild-type, D0928 and 0928C strains with
genomic DNA from a kanamycin-resistant S.
pneumoniae strain. P < 0.01 (ANOVA) for the
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impaired using S. pneumoniae genomic DNA carrying a
chloramphenicol-resistant marker as donor DNA(data not
shown).
Overall, the results of these assays demonstrate that
the D0928 strain has several phenotypes associated with
impaired ABC transporter function, suggesting that the
loss of Lsp function in this strain has resulted in wide-
spread effects on lipoprotein function.
Growth of the D0928 strain in complete and
stress media
Because of the wide range of cellular functions associ-
ated with different ABC transporters, global impairment
of ABC transporter function might be predicted to inhibit
growth of S. pneumoniae, especially under stress con-
ditions such as cation-depleted or osmotic stress media.
However, compared with the wild-type and 0928C
strains, the growth of the D0928 strain was not impaired
in an undeﬁned nutrient-rich medium (THY extract) or in
a chemically deﬁned medium (CDM), and was only
minimally impaired in THY treated with chelex-100
to remove cations (chelex-THY) or in THY containing
100 mM NaCl or 200 mM sucrose to create high osmotic
stress conditions (Brown et al., 2001a; 2004; Fig. 8A and
data not shown). However, S. pneumoniae is an obligate
human commensal or pathogen and, therefore, THY
does not adequately represent its natural environment.
To investigate whether loss of Lsp function in the D0928
strain results in impaired growth under physiologically
relevant conditions, freshly obtained human blood was
inoculated with 106 cfu ml-1 wild-type, D0928 and 0928C
strains and bacterial cfu after 4 h incubation calculated
by plating serial dilutions. For the D0928 strains, only
18% of the inoculum was viable after 4 h, compared with
67% and 108% for the wild-type and 0928C strains
(Fig. 8B), demonstrating that loss of Lsp function results
in impaired growth or survival in a physiologically rel-
evant growth medium.
Impaired virulence of the D0928 strain in mouse models
of septicaemia and pneumonia
The impaired survival of the D0928 strain in blood sug-
gested that this strain might be attenuated in virulence in
infection models. Hence, the virulence of the D0928 and
0928C strains were compared with the wild-type strain
using mixed infections and the competitive index (CI) in
mouse models of both septicaemia and pneumonia. In
both models for the comparison of the wild-type with
the D0928 strain, the CI was markedly reduced at
0.00013  0.00012 24 h after intraperitoneal (i.p.) inocu-
lation, and at 0.00001  0.000004 48 h after intranasal
(i.n.) inoculation (Fig. 9A and B). In contrast, mixed infec-
tions of the 0928C strain and the wild-type strain demon-
strated that the complemented strain was only slightly
reduced in virulence (CIs of 0.61  0.16 and 0.47  0.27
after i.p. or i.n. inoculation respectively), conﬁrming that
the loss of virulence of the D0928 strain was due to
deletion of lsp.
To further analyse the effects of loss of Lsp function on
virulence, bacterial cfu in the lungs and spleen 42 h after
inoculation (the time point just before fatal infection has
developed in mice inoculated with the wild-type S. pneu-
moniae strain) and the course of S. pneumoniae pulmo-
nary infection over time were assessed in groups of mice
given a pure inoculum i.n. of the wild-type or the D0928
strain. For mice infected with the D0928 strain, S. pneu-
moniae cfu in the lungs and spleen were 3.5 and 1.5 log10
lower 42 h after inoculation compared with mice infected
with the wild-type strain (Fig. 9C and D). In the time-
course infection experiments, the majority of mice inocu-
lated with the wild-type strain developed fatal infection
within 60 h, whereas by this time point, no mice infected
with D0928 had developed fatal infection (Fig. 9E).
However, by 168 h, lethal infection had developed in 90%
of mice infected with the D0928 strain. Bacteria recovered
from mice developing fatal infection after inoculation with
the D0928 strain were still resistant to erythromycin,
demonstrating that these bacteria had not lost the lsp
Fig. 8. A. Growth of the wild type (squares),
D0928 (diamonds) and 0928C (triangles)
strains in THY broth measured by OD580.
B. Bacterial cfu for the wild-type (clear
columns), D0928 (black columns) and 0928C
(grey columns) strains expressed as a
proportion of the inoculum after incubation in
human blood for 4 h. P < 0.01 (ANOVA) for the
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the development of infection with the D0928 strain was
signiﬁcantly delayed, this strain was still capable of
causing lethal infection.
Discussion
The importance of different lipoproteins for S. pneumo-
niae virulence and the identiﬁcation of an operon contain-
ing the putative S. pneumoniae lsp gene by STM screens
prompted our investigation of the function and the role of
Lsp in S. pneumoniae. The predicted protein encoded by
the putative S. pneumoniae lsp gene Sp0928 has high
levels of identity to Lsp from a variety of bacteria, as well
as identical conserved amino acids within functional
domains and the same predicted transmembrane proﬁle
as the B. subtilis Lsp. Expression of Sp0928 in E. coli
protected against globomycin, a cyclic peptide antibiotic
that is an antagonist of Lsp (Inukai et al., 1978), and
immunoblots and proteomic analysis of lipoproteins dem-
onstrated that in the D0928 strain the majority of the
identiﬁed lipoproteins have a slightly higher molecular
weight consistent with failure of cleavage of the
N-terminal signal peptide. Although absolute conﬁrmation
that Sp0928 encodes an Lsp would require sequencing
the N terminus of a range of lipoproteins from the D0928
strain, our data strongly support the results of the BLAST
searches suggesting that Sp0928 encodes the S. pneu-
moniae Lsp, and is essential for the processing of lipo-
proteins to the mature form.
The S. pneumoniae genome contains over 40 genes
that are predicted to encode lipoproteins (Bergmann and
Hammerschmidt, 2006), which existing data and by
analogy to described ABC transporters of other species
suggest, will contribute to a wide variety of cellular func-
tions important for growth and replication. The effects of
complete loss of function of all these lipoproteins there-
fore would be expected to have profound effects on S.
pneumoniae. However, despite changes in the size of at
least 13 lipoproteins, the lsp mutant strain had normal
Fig. 9. Assessment of the virulence of the
D0928 mutant strain.
A and B. CIs (expressed as log10) for the
D0928 and 0928C strains versus the wild-type
strain in mouse models of septicaemia (A)
and pneumonia (B). Each point represents the
CI for a single animal, and for both models,
P < 0.001 for the comparison of the CIs for
the D0928 and 0928C strains (Students
t-test).
C and D. Log10 ml
-1 bacterial cfu recovered
from the spleen (C) and lungs (D) from
groups of six mice 42 h after inoculation i.n.
with 10
6 cfu of the wild-type and D0928
strains. Results are shown as box and
whisker diagrams of the median cfu ml
-1 and
the interquartile range. For the comparisons
of the results for the D0928 strain versus the
wild-type strain for spleens and lungs
P = 0.047 and 0.033 (Mann–Whitney U-test)
respectively.
D. Time-course of the development of fatal
infection for groups of 10 mice inoculated i.n.
with 10
6 cfu of the wild-type and D0928 strains
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delay in stress media has been previously reported to
affect growth of S. pneumoniae strains with mutations in
speciﬁc ABC transporters (Brown et al., 2001a). These
results suggest that although loss of Lsp function resulted
in impaired processing of lipoproteins, these lipoproteins
still function adequately for the lsp mutant strain to grow
normally under the in vitro conditions investigated. Inves-
tigation of particular phenotypes associated with the func-
tion of speciﬁc ABC transporters (sensitivity to oxidative
stress, streptonigrin and penicillin, and transformation fre-
quency) demonstrated that these are all impaired in the S.
pneumoniae lsp-deletion strain, but not in the comple-
mented strain, conﬁrming that they were due to loss of lsp
rather than other effects in the mutated strain. Hence,
the lsp mutant strain does have widespread defects in
ABC transporter function, although these are not strong
enough to affect growth in laboratory media. This pheno-
type is broadly similar to that described for lsp mutant
strains of other Gram-positive bacteria, which contain
unprocessed prolipoprotein but, in contrast to E. coli, still
grow well in laboratory media (Isaki et al., 1990; Sankaran
and Wu, 1995; Tjalsma et al., 1999a; De Greef et al.,
2003; Reglier-Poupet et al., 2003; Venema et al., 2003).
However, in contrast to our results, mutation of the B.
subtilis lsp impairs growth under stress conditions without
affecting lipoprotein-dependent functions like genetic
competence, sporulation and germination (Tjalsma et al.,
1999a). These data as well as the other differences
between the phenotypes of lsp mutants in different bac-
terial species discussed below suggest that the effects of
loss of lsp on bacterial phenotypes in different Gram-
positive species cannot be easily predicted. For some
assays, the complemented lsp-deletion strain had
improved phenotypes compared with the wild-type strain
(growth in blood or THY, and transformation frequency).
The reasons for these observations are not fully under-
stood, but probably reﬂect the reduced expression of
Sp0929 and cbpE and the increased expression of
Sp0927 and lsp in the complemented 0928C strain. These
differences in gene transcription for the Sp0927–0930
operon may also explain why the 0928C strain is not fully
virulent, with a CI of 0.61 and 0.47 in the septicaemia and
pneumonia models respectively.
There are several mechanisms by which lipoprotein
function could be partially preserved in the S. pneumoniae
lsp mutant strain. Alternative processing pathways for
lipoproteins have been suggested for B. subtilis and
S. suis (Tjalsma et al., 1999a; De Greeff et al., 2003), and
these could potentially limit the effects of loss of Lsp
function. However, in the S. pneumoniae lsp mutant
strain, processed lipoprotein forms were possibly present
only for the non-ABC transporter lipoproteins, PpmA and
SlrA, and alternative processing of lipoproteins is there-
fore unlikely to account for the almost normal growth of
the lsp mutant strain in laboratory media. Although recent
evidence suggests that Lsp activity in L. monocytogenes
does not require Lgt (Baumgärtner et al., 2007), for most
eubacteria lipid attachment of prolipoproteins has gener-
ally been accepted to occur before Lsp activity (Tokunaga
et al., 1982; Sankaran and Wu, 1995; Sutcliff and Har-
rington, 2002). Using antibodies to lipoproteins and immu-
noblots of Triton X-114 extracts, ﬂow cytometry assays
and electron microscopy, we have demonstrated that S.
pneumoniae follows this general model of lipoprotein pro-
cessing, with lipoproteins still present in the detergent
phase and expressed on the bacterial surface in the S.
pneumoniae lsp mutant strain. Hence, despite incomplete
processing, lipoproteins in the S. pneumoniae lsp mutant
strain are still attached to cell membranes and could
remain at least partly functional. The ﬂow cytometry data
also suggested that there was a higher level of expression
of PiuA in the lsp mutant strain, and overexpression of
ABC transporters may provide some compensation for
the impaired function of unprocessed lipoproteins. In addi-
tion, functions of individual ABC transporters are fre-
quently redundant and shared with non-ABC transporter
import systems (e.g. sugar transport; Tettelin et al., 2001),
and this could limit the effects on growth of loss of Lsp
function. Full evaluation of any compensatory mecha-
nisms for loss of Lsp function in the S. pneumoniae lsp
mutant strain will provide a better understanding of the
importance of different lipoprotein functions and requires
further investigation.
Although the S. pneumoniae lsp mutant strain grew well
in laboratory media, the growth of this strain was signiﬁ-
cantly impaired in blood compared with the wild-type
strain. Growth in blood is likely to cause markedly more
physiological stress (e.g. through nutrient and mineral
limitation, and oxidative and osmotic stress) on S. pneu-
moniae than growth in complete laboratory media. Partial
impairment of ABC transporter and non-ABC transporter
lipoprotein functions under these conditions could there-
fore lead to signiﬁcant growth or survival defects. The
impaired survival and/or growth of the lsp mutant strain in
blood was reﬂected in the results of the virulence assays,
which demonstrated a markedly impaired CI for the lsp
mutant strain in mouse models of both the pneumonia and
septicaemia, and recovery of fewer bacteria from target
organs 48 h after i.n. inoculation compared with the wild-
type strain. However, the majority of mice infected with the
lsp mutant strain did develop fatal infection, indicating that
the lsp mutant strain has delayed replication during infec-
tion rather than an inability to cause fatal disease. The
cumulative effects of total loss of function of the numerous
lipoproteins and ABC transporters required for virulence
(Dintilhac et al., 1997; Polissi et al., 1998; Brown et al.,
2001a; 2002; Lau et al., 2001; Hava and Camilli, 2002;
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virulence. This is illustrated by dual mutation of the Piu
and Pia iron uptake ABC transporters alone or deletion of
lgt, possibly leading to failure to retain lipoproteins on the
cell membrane, both of which completely abrogate S.
pneumoniae virulence in mice models of pneumonia
(Brown et al., 2001a; Petit et al., 2001). Therefore, the
ability of the S. pneumoniae lsp mutant to still cause fatal
disease reinforces that there is only partial impairment of
ABC transporter and lipoprotein function in this strain.
Deletion of lsp also affects the virulence of the Gram-
positive pathogens L. monocytogenes and M. tuberculo-
sis (Reglier-Poupet et al., 2003; Sander et al., 2004), but
not S. suis (De Greeff et al., 2003). Why loss of Lsp does
not affect the virulence of S. suis but has a signiﬁcant
effect on in vivo replication of its close relative S. pneu-
moniae requires further evaluation. Furthermore, in con-
trast to the results for S. pneumoniae, mutation of the S.
aureus lgt actually enhances virulence, despite leading to
loss of lipoproteins from the bacterial surface (Warden-
burg et al., 2006). This is thought to be due to the loss of
surface lipoproteins reducing recognition of the mutant
strain by Toll-like receptors (Stoll et al., 2005; Wardenburg
et al., 2006).
To summarize, we have conﬁrmed that Sp0928
encodes the S. pneumoniae Lsp and described the phe-
notype of a strain in which this gene has been deleted.
The data show that in S. pneumoniae Lsp is required for
cleavage of the lipoprotein signal peptide sequence after
attachment to the cell membrane, and that loss of Lsp
leads to accumulation of immature lipoproteins, impaired
ABC transporter function and reduced S. pneumoniae
replication in animal models of infection. It is likely that
Lsp will be important for disease pathogenesis of other
bacterial pathogens, and therefore may offer a potential
target for novel therapeutic agents. However, there are
signiﬁcant differences in the effects of loss of lsp between
even relatively closely related bacterial species, and the
effects of deletion of lsp on the in vitro and in vivo
phenotypes of S. pneumoniae indicate that lipoprotein
function is only partially affected. Further research is nec-
essary to clarify the roles of Lsp in different bacteria, and
the mechanisms by which S. pneumoniae can compen-
sate for loss of Lsp function.
Experimental procedures
Bacterial strains and culture conditions
Streptococcus pneumoniae strains used in this work are listed
in Table 3. The mutant strains used for this work were con-
structed in the 0100993 capsular serotype 3 clinical isolate
(Lau et al., 2001). S. pneumoniae strains were cultured at
37°C and 5% CO2 on Columbia agar supplemented with 5%
horse blood, in THY or CDM (Samen et al., 2004). Chloram-
phenicol (10 mgm l
-1), erythromycin (0.2 mgm l
-1), spectinomy-
cin (200 mgm l
-1) and kanamycin (1 mg ml
-1) were added to
blood agar plates where appropriate. Cations were depleted
from the THY medium using 2% chelex-100 (Bio-Rad) and
THY NaCl as previously described (Brown et al., 2001a;
2004). The growth of different strains were compared in broth
culturebymeasuringOD580athourlyintervals.Workingstocks
of bacterial cultures in THY (OD580 0.3–0.4) were stored at
-80°C with 10% glycerol. Plasmids were ampliﬁed in E. coli
strain DH5a, grown at 37°C on Luria–Bertani (LB) medium
with appropriate selection (Sambrook et al., 1989).
Construction of mutant strains
For the in-frame deletion of Sp0928, a construct was created
in which 784 bp of ﬂanking DNA 5′ to the Sp0928 ATG
(primers Sp0927F and Ery-Sp0927R) and 669 bp of ﬂank-
ing DNA 3′ to the Sp0928 ORF (starting from the ATG of
the overlapping Sp0929 ORF, primers Ery-Sp0929F and
Sp0929R) were ampliﬁed by PCR and fused with the erm
cassette from pACH74 (a suicide vector carrying erm for
selection in S. pneumoniae, a kind gift from J. Paton) by
overlap extension PCR (Link et al., 1997). For complemen-
tation of the D0928 strain, a construct was made using
overlap extension PCR that consisted of the following PCR
products: the full-length Sp0928 ORF and 626 bp of Sp0927
(primers Sp0927F and Cm-Sp0928R); the chloramphenicol-
resistance marker (cat, primers CmF and CmR); and 677 bp
sequence 3′ to Sp0928 starting at the ATG codon of Sp0929
(primers Cm-Sp0929F and Sp0929R). Primers used for the
overlap extension PCRs are shown in Table 3. These con-
structs were transformed into S. pneumoniae by homologous
recombination and allelic replacement using CSP-1 and stan-
dard protocols (Havarstein et al., 1995; Lau et al., 2001). The
identity and accuracy of the mutations were conﬁrmed by
PCR analysis and sequencing. Both the D0928 and 0928C
strains were stable after two 8 h growth cycles in THY with-




mutant strains in the 0100993 background were constructed




– (kind gift from Peter Hermans; McCluskey
et al., 2004; Hermans et al., 2006), and the JSB3pstS
–
mutant strain using the pstS disruption vector pHS102 (kind
gift from Marc Ouellette; Soualhine et al., 2005).
DNA, RNA extraction and RT PCR
Genomic DNA and total RNA were isolated from S. pneumo-
niae strains using the Wizard genomic DNA isolation kit and
the SV total RNA isolation system (Promega) respectively,
following the manufacturer’s instructions except that cells
were incubated with 0.1% deoxycholic acid (Sigma) at 37°C
for 10 min before extraction. 0.5% RNasin (Promega) was
added to extracted RNAto prevent it from degradation. cDNA
was derived and ampliﬁed from RNA using the Access
RT-PCR system (Promega) and target-speciﬁc primers. The
following primer pairs were used for the transcriptional analy-
sis of the Sp0927–0930 operon structure: Sp0926.1 and
Sp0927.1 for the junction between Sp0926 and Sp0927;
Sp0927.2 and Sp0928.1 for Sp0927 and Sp0928; Sp0928.2
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Sp0930.1 for Sp0929 and Sp0930; Sp0930.2 and Sp0931.1
for the junctions between Sp0930 and Sp0931 (Table 3). DNA
contamination of all RNA samples was excluded by RT-PCR
with no reverse transcriptase failing to result in a product.
Real-time RT-PCR
cDNA was derived and ampliﬁed from 1 mg of total RNA in a
20 ml reaction volume using the Applied Biosystems
Geneamp RNA PCR core kit (Applied Biosystems, UK)
according to the manufacturer’s instructions. Target-speciﬁc
primers used for the analysis of gene expression of individual
genes within the Sp0927–0930 operon are described in
Table 3 (primers prefaced by RT-). Real-time RT-PCR was
conducted using the Platinum SYBR Green qPCR SuperMix
UDG (Invitrogen, UK) on a LightCycler 1.5 Real-time Detec-
tion System (Roche, UK), and analysed using LightCycler
Real-time PCR Detection System Software Version 3.5.
Cycling conditions were as follows: one cycle of 50°C (2 min),
Table 3. Strains, plasmids and primers constructed and used in this study.
Name Description/sequence (source/reference)
Strains
0100993 S. pneumoniae capsular serotype 3 clinical isolate (Lau et al., 2001)
D0928 0100993 with in-frame deletion of Sp0928: ery
r (this study)




– 0100993 containing an insertion in piuB and in piaA: ery
r cm
r (Brown et al., 2001a)
TIGR4-psaA
– S. pneumoniae TIGR4 strain with mariner mutation in psaA: spec
r (McCluskey et al., 2004)
JSB3psaA
– 0100993 with mariner mutation in psaA: spec
r (this study)
JSB3pstS
– 0100993 containing chromosomal insertion of pHS102: cm
r (this study)
D39DslrA S. pneumoniae D39 strain with deletion of slrA: ery
r (Hermans et al., 2006)
JSB3slrA
– 0100993 with deletion of slrA: ery
r (this study)
JSB3ppmA
– 0100993 with deletion of ppmA: ery
r (this study)
Plasmids
pPC143 pQE30UA carrying full-length Sp0928 from 0100993: Km
r, Amp
r (this study)
pPC138 pQE30UA carrying full-length Sp0149 from 0100993: Km
r, Amp
r (this study)
pHS102 Disruption vector for the S. pneumoniae pstS gene: cm







































Streptococcus pneumoniae Lsp 553
© 2007 The Authors
Journal compilation © 2007 Blackwell Publishing Ltd, Molecular Microbiology, 67, 541–55795°C (2 min); 45 cycles of 95°C (5 s), 55°C (5 s), 72°C (15 s).
The speciﬁcity of the PCR product was conﬁrmed by melting
curve analysis and gel electrophoresis. For each gene, cross-
ing point (Cp) values were determined from the linear region
of the ampliﬁcation plot and normalized by subtraction of the
Cp value for 16S RNA generating a DCp value. Relative
change was determined by subtraction of the DCp value for
the wild-type strain from the DCp value for the mutant strain




Stationary phase E. coli cells were diluted 1:50 in LB




were inoculated (5%) in fresh LB containing different concen-
trations of globomycin (kind gift from Masatoshi Inukai, Inter-
nationalUniversityofHealthandWelfare,Tochigi,Japan).The
growth was then assessed by OD600 measurement after 16 h
growth at 37°C and 220 rotations per min.
Protein immunoblots and Triton X-114 extraction
Protein samples from whole-cell lysates and Triton X-114
extracts were separated on SDS-PAGE 10% and 15% resolv-
ing gels respectively, blotted onto nitrocellulose membranes
and probed with speciﬁc antisera (1:2500 dilution) according
to standard protocols (Sambrook et al., 1989). Membrane
proteins were extracted by Triton X-114 extraction according
to Bordier (1981) with modiﬁcations described by Cockayne
et al. (1998). Brieﬂy, exponentially growing S. pneumoniae
cells were pelleted and digested with 100 ml of 0.1% DOC
(Sigma) in PBS for 30 min at 37°C. The digested pellets were
sonicated with three pulses of 15 s with a 10 s cooling time
using a Soniprep 150 (Sanyo) ultrasonicator. Eight hundred
microlitres of PBS and 100 ml of Triton X-114 (10% in PBS)
were then added to the lysates, which were incubated at 4°C
for 2 h, followed by centrifugation at 13 000 g for 10 min at
4°C to pellet insoluble debris. Supernatants were then incu-
bated at 37°C for 30 min to allow phase separation, followed
by centrifugation at room temperature to pellet the detergent
phase proteins. The detergent phase pellet was then washed
with 1 ml of PBS at 4°C for 1 h, followed by incubation at
37°C for 30 min and centrifugation to pellet the proteins. The
detergent phase proteins were diluted 1:2 in PBS prior to
solubilization in Laemmli sample buffer for SDS-PAGE.
Global analysis of lipoproteins
For proteomic studies, wild-type and mutant strains were
cultured in Brain Heart Infusion broth (Oxoid) until late expo-
nential phase. Lipoproteins were extracted by treatment of
washed cell suspensions with Triton X-114 as above except
that cells were treated with mutanolysin and lysozyme.
Extracts were analysed by SDS-PAGE (10% acrylamide),
and gels were stained with Colloidal Coomassie brilliant blue
(Sigma). Bands were excised from gels, and proteins were
digested in gel with sequencing grade trypsin (Promega)
(Wilkins et al., 2001). Tryptic digests were analysed by
LC-MS/MS using a ProteomeX system (Thermo Scientiﬁc,
Hemel Hempstead, Hertfordshire, UK). Chromatography was
performed on a 100 ¥ 0.18 mm BioBasic C18 column (Thermo
Scientiﬁc). Peptides were eluted with aqueous ACN (5–80%
ACN over 90 min) containing 0.1% formic acid at a ﬂow rate
of 2 ml min
-1. Spectra were acquired in data-dependent
MS/MS mode with dynamic exclusion prior to analysis using
TurboSEQUEST software (Bioworks version 3.2; Thermo
Scientiﬁc). Lipoproteins were identiﬁed using MS/MS data to
interrogate the translated genomic sequence of the S. pneu-
moniae strains TIGR4, D39 and R6 (the J. Craig Venter
Institute, JCVI; http://www.jcvi.org/). MS/MS spectra were
required to have XCorr values of at least 1.5, 2.0 and 2.5 for
peptides with a single, double or triple charge respectively, in
order for these to be included in analyses.
Lipoprotein expression analysis
Flow cytometry assays for the binding of polyclonal antiserum
to the lipoproteins PiuA and SlrA on live S. pneumoniae were
performed using a previously described protocol (Jomaa
et al., 2005), affinity puriﬁed polyclonal antiserum to PiuA,
PpmA and SlrA (1:50 dilution in PBS), and a 1:100 dilution of
phycoerythrin-conjugated goat anti-rabbit (Sigma).After incu-
bation on ice for 30 min, the bacteria were washed with
500 ml of PBS-0.1% Tween 20 and resuspended in 400 mlo f
PBS for ﬂow cytometry analysis. Results are presented as
the percentage of bacteria from each species bound with




– strains as negative
controls.
Immunoelectron microscopy
Immunoelectron microscopy of S. pneumoniae was per-
formed as previously described (Overweg et al., 2000). S.
pneumoniae cells (10
8 cfu) were ﬁxed in a mixture of 4%
formaldehyde and 0.1% glutaraldehyde, embedded in low-
melting agarose (Sigma) and dehydrated in a graded series
of methanol solutions (25–100%). They were then embedded
in lowicryl K4M resin (Agar Scienﬁc, UK) with UV polymer-
ization, and ultra-thin sections were transferred to Formvar-
coated copper grids. The immunostaining was performed as
described by Overweg et al. (2000) and examined with a
JEOL JEM-1010 transmission electron microscope at 80 kV.
ABC transporter phenotype analysis
Sensitivity to oxidative stress and cation transport were
studied by exposure of S. pneumoniae strains (10
6 cfu) to
60 mM paraquat (Sigma; Tseng et al., 2002) or 2 mgm l
-1
streptonigrin (Sigma; Brown et al., 2001a) at 37°C for 60 and
30 min respectively. The proportion of survivors after the
exposure was calculated by plating serial dilutions on blood
agar plates. For penicillin sensitivity, 10
6 cfu of exponentially
growing S. pneumoniae cells were diluted in THY broth con-
taining 7.5 ng ml
-1 penicillin (Sigma), and the extent of growth
was assessed by OD580 measurements after incubation at
37°C and 5% CO2 for 10 h. To compare transformation fre-
quency, test strains at an OD580 of 0.015 were transformed
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with 5 ng of S. pneumoniae genomic DNA containing a
marker for kanamycin or chloramphenicol resistance.
In vivo studies
All animal experiments conformed to institutional and govern-
mental guidelines and regulations. Outbred CD1 female
white mice (Charles Rivers Breeders) weighing 18–22 g were
used for animal infection experiments. For the pneumonia
model, mice were anaesthetized by inhalation of halothane
(Zeneca) and inoculated i.n. with an inoculum volume of
50 ml, and for the septicaemia model by i.p. inoculation of an
inoculum of 100 ml. Mixed infection experiments were used to
calculate CIs (the ratio of mutant to wild-type strain recovered
from the mice divided by the ratio of mutant to wild-type strain
in the inoculum), using 5 ¥ 10
6 cfu each of the wild-type and
mutant strains for the pneumonia model, and 4 ¥ 10
3 cfu
each in 100 ml for the septicaemia model and groups of four
or ﬁve mice. Mice were sacriﬁced after 24 h (septicaemia
model) or 48 h (pneumonia model), target organs recovered
and homogenized in 0.5 ml of 0.9% saline, before plating
dilutions on non-selective and selective medium for calcula-
tion of the CI. To compare the course of disease between the
D0928 and wild-type strains, groups of 10 mice were inocu-
lated with 10
6 cfu i.n. of each strain and closely observed over
the next 14 days. Mice were sacriﬁced when they exhibited
the following signs of disease: hunched posture, poor mobil-
ity, weight loss, coughing and tachypnoea. Additional groups
of six mice were sacriﬁced 42 h after inoculation for calcula-
tion of bacterial cfu within the lungs and spleens by plating
serial dilutions of organ homogenates.
Statistical analysis of results
All in vitro data use three or more samples per strain tested,
and are representative of experiments repeated at least twice
that gave similar results. Results for phenotype assays were
compared between strains using Student’s t-test or ANOVA.
CIs for the D0928 and 0928C strains were compared using
Student’s t-test, and bacterial cfu from target organs com-
pared using the Mann–Whitney U-test. Experiments compar-
ing the course of disease between the D0928 and wild-type
strains were repeated twice, giving similar results, and the
data were analysed using the log rank method.
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